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Despite antibiotics and sterile technique, postoperative infections remain a real and present danger to patients. Recent estimates suggest that 50% of
the pathogens associated with postoperative infections have become resistant to
the standard antibiotics used for prophylaxis. Risk factors identiﬁed in such cases include obesity and antibiotic exposure. To study the combined effect of obesity and
antibiotic exposure on postoperative infection, mice were allowed to gain weight on
an obesogenic Western-type diet (WD), administered antibiotics and then subjected
to an otherwise recoverable sterile surgical injury (30% hepatectomy). The feeding of
a WD alone resulted in a major imbalance of the cecal microbiota characterized by a
decrease in diversity, loss of Bacteroidetes, a bloom in Proteobacteria, and the emergence of antibiotic-resistant organisms among the cecal microbiota. When WD-fed
mice were administered antibiotics and subjected to 30% liver resection, lethal sepsis, characterized by multiple-organ damage, developed. Notable was the emergence
and systemic dissemination of multidrug-resistant (MDR) pathobionts, including
carbapenem-resistant, extended-spectrum ␤-lactamase-producing Serratia marcescens, which expressed a virulent and immunosuppressive phenotype. Analysis of
the distribution of exact sequence variants belonging to the genus Serratia suggested that these strains originated from the cecal mucosa. No mortality or MDR
pathogens were observed in identically treated mice fed a standard chow diet.
Taken together, these results suggest that consumption of a Western diet and exposure to certain antibiotics may predispose to life-threating postoperative infection
associated with MDR organisms present among the gut microbiota.

ABSTRACT

IMPORTANCE Obesity remains a prevalent and independent risk factor for life-

threatening infection following major surgery. Here, we demonstrate that when mice
are fed an obesogenic Western diet (WD), they become susceptible to lethal sepsis
with multiple organ damage after exposure to antibiotics and an otherwiserecoverable surgical injury. Analysis of the gut microbiota in this model demonstrates that WD alone leads to loss of Bacteroidetes, a bloom of Proteobacteria, and
evidence of antibiotic resistance development even before antibiotics are administered. After antibiotics and surgery, lethal sepsis with organ damage developed in in
mice fed a WD with the appearance of multidrug-resistant pathogens in the liver,
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spleen, and blood. The importance of these ﬁndings lies in exposing how the selective pressures of diet, antibiotic exposure, and surgical injury can converge on the
microbiome, resulting in lethal sepsis and organ damage without the introduction of
an exogenous pathogen.
KEYWORDS Western diet, gut microbiome, gut-derived sepsis, pathobionts, surgery
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he most common, costly, and deadly complication after major surgery is infection
(1–3). Despite the use of broader and more frequent dosing of antibiotics, surgical
infections continue to occur at unacceptable rates. Recent data indicate that 50% of all
surgical-site infections are now due to organisms that have become resistant to the
standard antibiotics used for prophylaxis (4, 5). Although the precise source of these
pathogens is unknown, in humans, the gut has been identiﬁed as a major reservoir for
antibiotic-resistant bacteria (6, 7). Precisely how pathogenic organisms in the gut might
contribute to postoperative infection, however, remains unknown.
The microbiome a given patient harbors prior to undergoing major surgery is
unknown and is likely to be affected not only by diet but also by recent antibiotic
exposure, travel history, and the diagnosis of the underlying disease for which surgery
is being performed, such as cancer (8, 9). Patients are often exposed to multiple and
prolonged antibiotics prior to high-risk surgery when they undergo biopsies, radiation,
or chemotherapy or present with an infection. The extent to which these exposures
alter the intestinal microbiome and the inﬂuence of the altered microbiome on
postoperative infection are largely unknown (10). Compounding these factors is the
observation that more than 30% of patients undergoing major surgery in the United
States are obese (11), which itself is an independent risk factor for the development of
all postoperative infections (12, 13). In the present study, we hypothesized that an
obesogenic diet, combined with antibiotic exposure, would predispose a host to
infection-related morbidity following a major surgical intervention via effects that
involve the intestinal microbiome. Therefore, the aims of the present study were to (i)
create a novel mouse model of lethal infection in which mice are fed an obesogenic
diet, are administered antibiotics, and undergo an otherwise recoverable sterile surgical
injury, and (ii) deﬁne the microbiota and pathobionts that are associated with lethal
infection in this model and determine their source, antibiotic resistance patterns, and
effect on immune cell function. Results indicate that an obesogenic diet and antibiotic
exposure impose selective pressure on the intestinal microbiota such that lethal
infection develops following an otherwise-recoverable surgical injury. As far as we are
aware, this is the ﬁrst animal model to demonstrate spontaneous emergence and
dissemination of virulent, drug-resistant pathobionts with multiple-organ failure and
lethal sepsis without the introduction of an exogenous pathogen.
RESULTS
The cecal microbiota of Western diet-fed mice demonstrates loss of bacteroidetes, a bloom in proteobacteria, and antibiotic resistance. Mice were fed a
high-fat/low-ﬁber Western diet (WD) diet versus chow for 40 days. WD-fed mice displayed a signiﬁcant increase in weight compared to chow-fed mice (n ⫽ 4 for chow
group and n ⫽ 5 per Western group; *, P ⬍ 0.001 [t test]) (Fig. 1A) with typical fat
deposition in the liver. Serum C-reactive protein (CRP), interleukin-6 (IL-6), and body
temperature (see Fig. S1A to C in the supplemental material) trended higher in WD-fed
mice with the rare detection of positive cultures within the blood, liver, and spleen (see
Fig. S1D in the supplemental material). A signiﬁcant alteration in cecal microbiota
composition and function was observed (Fig. 1B to E). A decrease in total bacterial
density in the cecal tissue-associated microbiota was observed in WD-fed mice by
quantitative PCR (qPCR) (Fig. 1B), as well as a signiﬁcant decrease in alpha diversity in
both the lumen and tissue-associated microbiota, as measured by Shannon and inverse
Simpson indexes (Fig. 1C). Microbiota composition was signiﬁcantly different between
WD- and chow-fed mice in both the lumen and tissue compartments (cecum) based on
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FIG 1 Role of Western diet on gut microbial structure, membership, and function. (A) Change in mouse weight
(%) over time: Western diet (open circles) versus chow (solid circles). *, P ⬍ 0.0001 (chow, n ⫽ 4; Western diet,
n ⫽ 5). Statistical bars depict the standard errors (SEM). (B) Total bacterial DNA concentration in cecal tissue as
determined by qPCR (n ⫽ 5 per group, P ⫽ 0.037 [nonparametric Mann-Whitney test]). (C) Alpha diversity
based on Shannon and inverse Simpson (invSimpson) indexes. Asterisks indicate statistical signiﬁcant differences (n ⫽ 5 mice per group; *, P ⬍ 0.05). (D) Nonmetric multidimensional scaling (NMDS) plots based on
weighted UniFrac dissimilarity matrix between the four groups (n ⫽ 5 mice per group). The multigroup
PERMANOVA revealed signiﬁcant differences between groups: chow lumen versus chow tissue (P ⫽ 0.01); chow
tissue versus Western tissue (P ⫽ 0.002); and chow lumen versus Western lumen (P ⫽ 0.004). There was no
signiﬁcant difference for Western lumen versus Western tissue. (E) Stack plots showing distribution of phyla
with a relative abundance of ⬎2%. The taxa with ⬍2% abundance are placed under one category, i.e., “⬍2%.”
Statistical analysis tested for the differential abundance at a P value of ⬍0.05 with the Benjamini-Hochberg FDR
correction in ANCOM (n ⫽ 5 mice per group). (F and G) Heat maps of phenotype microarrays tested with GENIII
plate under anaerobic (F) and aerobic (G) conditions (chow, n ⫽ 4; Western diet, n ⫽ 5). (H) Radial plot
representing the set of substrates with signiﬁcantly higher metabolic activity of microbial populations from
Western diet-fed versus chow-fed mice. Radial numbers represent the AUC values. Each line on the plot
represents an individual mouse. The degree to which the line deviates toward a given metabolite on the plot
represents the predisposition of the bacterial community to metabolize that metabolite.

a weighted UniFrac metric (Fig. 1D). In the lumen, the Bacteroidetes/Firmicutes/Proteobacteria (B:F:P) ratio was 16:25:0 in chow-fed mice versus 1:375:125 in WD-fed mice. In
the tissues, the B:F:P ratio was 220:245:3 in chow-fed mice versus 9:680:300 in WD-fed
mice (Fig. 1E). Compositional changes in the microbiota were accompanied by functional changes, as judged by phenotypic microarray analysis performed under anaerobic (Fig. 1F) and aerobic (Fig. 1G) conditions. Under anaerobic conditions, microbiota
in WD-fed mice displayed a lower metabolic activity pattern compared to chow-fed
July/August 2019 Volume 10 Issue 4 e00903-19
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mice (Fig. 1F). The opposite effect was observed under aerobic conditions (Fig. 1G). The
low metabolic activity of the microbiota under anaerobic conditions in WD mice was
consistent with the loss of Bacteroidetes, whereas high metabolic activity under aerobic
conditions was consistent with the observed bloom in Proteobacteria. A higher saccharolytic potential was observed in the microbiota of WD-fed mice based on a signiﬁcant
increase in glucose and gluconic acid consumption. In addition, the antibiotic resistance potential observed in the microbiota of WD-fed mice was striking, as judged by
their signiﬁcant growth in the presence of aztreonam (Fig. 1H). Analysis of the entire
carbohydrate set on the GENIII plates demonstrated a clear pattern of a preference of
multiple carbohydrate consumption under aerobic conditions among the microbiota of
WD-fed mice (see Fig. S2 in the supplemental material).
WD-fed mice exposed to antibiotics develop lethal sepsis following an otherwise recoverable and sterile surgical injury. After 6 weeks on either a Western-type
(W) or Chow (C) diet, mice were exposed to 5 days of antibiotic treatment with cefoxitin
and clindamycin (A), preoperative starvation (S) (water only the night prior to surgery),
and a 30% surgical hepatectomy (H) (i.e., CASH versus WASH) (Fig. 2A). A 30%
hepatectomy is performed in ⬍15 min and is a completely recoverable injury (14, 15).
The morbidity score and survival curves demonstrated that the full complement WASH
treatment was needed for morbidity and mortality to occur (Fig. 2B to F). Without
antibiotic treatment (i.e., WSH or CSH), mice survived surgery with complete recovery
to normal health status (Fig. 2B and C). Preoperative antibiotic treatment (cefoxitin, a
broad-spectrum, second-generation cephalosporin, and clindamycin, a lincosamide
antibiotic speciﬁc for anaerobes) signiﬁcantly altered the postsurgical outcome which
was highly dependent on the Western diet (Fig. 2D and E). In CASH-treated mice, only
2 of 15 animals developed a morbidity score of 5 (Fig. 2D). WASH-treated mice became
moribund by 24 h, and 10 of 15 mice received the highest morbidity score of 5 at 40 h
postoperatively (Fig. 2E). Kaplan-Meyer survival curves demonstrated 70% sepsis related mortality in WASH-treated mice (Fig. 2F).
CRP (Fig. 2G) and IL-6 (Fig. 2H) were signiﬁcantly elevated in the blood of WASHtreated mice. This was associated with a high degree of dissemination of Gram-negative
bacteria (105 to 107 CFU/g of tissue or ml of blood) (Fig. 2I). The dissemination of
Gram-positive bacteria was negligible compared to Gram-negative bacteria (102 CFU/g
in tissues and sterile blood) in CASH-treated mice and absent in all samples from
WASH-treated mice. When integrating all experimental runs and aggregated data, a low
percentage of dissemination and mortality was observed in CASH-treated mice compared to a high percentages in WASH-treated mice (Fig. 2J).
Representative histology of the lungs, the most common organ affected in animal
models of sepsis, demonstrated heavy inﬁltration of inﬂammatory cells and collapse of
alveoli in WASH-treated mice (Fig. 3C), which was markedly attenuated in the lungs of
CASH-treated mice (Fig. 3B) and absent in normal untreated chow-fed mice (Fig. 3A).
Domination by pathobionts in WASH-treated mice is associated with apoptosis
at the bases of cecal crypts. 16S rRNA gene sequence analysis revealed a signiﬁcant
loss of alpha diversity in both lumen and tissue-associated microbiota on postoperative
day 2 (POD2) independent of diet (Fig. 4A and B). Alpha diversity (Shannon diversity
index) (Fig. 4A) decreased signiﬁcantly in both WASH- and CASH-treated mice. By the
inverse Simpson (Fig. 4B), diversity was also decreased in both groups but was
signiﬁcantly decreased in WASH-treated mice. Microbiota composition was also significantly altered on POD2 in both groups and across both compartments (cecal lumen
and tissue-associated) based on the weighted UniFrac metric (Fig. 4C). The B:F:P ratio
was shifted toward Proteobacteria in all groups: 1:10:30 in the lumen and 120:1:60 in the
tissues in CASH-treated mice versus 0:0:100 in the lumens and 0:50:50 in the tissueassociated microbiota in WASH-treated mice (Fig. 4D). Notable, however, was the
persistence of Bacteroidetes in the cecal tissues of CASH-treated mice but not in
WASH-treated mice (Fig. 4D). At the genus level, most bacteria in the lumens of
CASH-treated mice were unclassiﬁed; tissues from CASH-treated mice were dominated
by Bacteroides; most bacteria in the lumens of WASH-treated mice were identiﬁed as
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FIG 2 Effect of Western diet (W) on lethal sepsis following antibiotic exposure (A), short-term starvation (S), and a 30%
hepatectomy (H) (WASH). (A) Experimental protocol. (B to E) Postoperative morbidity scores in CSH (chow ⫹ starvation ⫹
hepatectomy), CASH (chow ⫹ antibiotics ⫹ starvation ⫹ hepatectomy), WSH (Western diet ⫹ starvation ⫹ hepatectomy), and
WASH (Western diet ⫹ antibiotics ⫹ starvation ⫹ hepatectomy). Morbidity scores (MS): MS1, healthy mice; MS2, rufﬂed fur, normal
fecal pellets (three to four pellets over 24 h); MS3, rufﬂed fur, fewer fecal pellets (one to two pellets over 24 h), hunched posture,
increased respirations; MS4, rufﬂed fur, no pellets, hunched posture, increased respirations, do not move to touch; and MS5,
animal on side, minimally responsive, rapid shallow respirations, gasping, moribund. WASH treatment compared to all groups:
P ⬍ 0.0001 at 18, 24, 30, 36, and 40 h (n ⫽ 15/group [two-way ANOVA]). (F) Kaplan-Meier survival curves. WASH treatment
compared to all other groups: P ⬍ 0.0001 (n ⫽ 15 mice/group, log-rank [Mantel-Cox] test). (G) Serum CRP for CASH and WASH
treatments in blood samples collected at POD2 (n ⫽ 5 per group; *, P ⫽ 0.0008 [by t test]). Statistical bars depict the SEM. (H)
Serum IL-6 from CASH and WASH treatments (n ⫽ 5 per group; *, P ⫽ 0.0135 [by t test]). Statistical bars depict the SEM. (I)
Quantitative culture results on MacConkey plates: *, P ⫽ 0.003 (n ⫽ 5 per group [Mann-Whitney test]). (J) Percent mortality/
dissemination across all experimental runs (n ⫽ 30, CASH treatment group; n ⫽ 40, WASH treatment group).

Pseudomonas. In the tissues of WASH-treated mice Pseudomonas and Serratia dominated (Fig. 4E; see Table S2 in the supplemental material). To determine whether
disseminated Serratia originated from the cecum, qPCR analysis of cecal tissues from
Chow diet, WD, CASH-, and WASH-treated mice was performed. The results indicated
the presence of Serratia marcescens DNA in all four groups, including untreated chow
diet-fed mice (Fig. 4F). The cecal tissue S. marcescens DNA levels were signiﬁcantly
higher in WD-fed mice versus chow-fed mice, with the highest levels in WASH-treated
mice (Fig. 4F). Using DeBlur and 16S rRNA amplicon sequence analysis, we determined
the distinct organ distribution of exact sequence variants (ESVs) belonging to Serratia
and Pseudomonas, two abundant genera in the cecal tissues of WASH-treated mice. We
July/August 2019 Volume 10 Issue 4 e00903-19
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FIG 3 Effect of WASH treatment on organ damage. The lung histology of untreated (A), CASH-treated
(B), and WASH-treated (C) mice is shown.

identiﬁed nine ESVs of Pseudomonas, among which, ESV7 was dominant in the cecal
lumens of CSH- and WASH-treated mice. None of the Pseudomonas ESVs were dominant in extraintestinal organs (Fig. 4G). We also found two Serratia ESVs; among them,
Serratia ESV2 was detected at very low abundance (0.05%) in the cecal tissue of
untreated chow-fed mice. Notably, its abundance reached 2% following surgery in mice
without preoperative antibiotic treatment and 30 to 60% in extraintestinal organs
following antibiotic treatment and surgery (30% hepatectomy) (Fig. 4G). More abundant Serratia ESV2 was observed in livers and spleens in WASH-treated mice. To conﬁrm
the presence of S. marcescens in cecal tissues of nontreated mice, ﬂuorescent in situ
hybridization (FISH) was performed. S. marcescens was identiﬁed within bacterial
clusters located at the bases of the cecal crypts (Fig. 4H), similar to what others have
demonstrated for Proteobacteria (16).
Next, we determined if the Serratia and Pseudomonas within tissue-associated
microbiota has a signiﬁcant effect on cecal crypt function using TUNEL (terminal
deoxynucleotidyl transferase dUTP nick end labeling) staining (Fig. 5). Representative
images indicated that apoptotic cells localize to the tops of crypts in CASH-treated mice
(Fig. 5A), whereas they are concentrated at the base of cecal crypts in WASH-treated
mice (Fig. 5B). Quantitative analysis demonstrated that the overall percentage of
July/August 2019 Volume 10 Issue 4 e00903-19
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FIG 5 Effect of WASH treatment on cecal crypts. (A and B) Representative images demonstrating the
abundance and distribution of TUNEL-positive cells in the cecal crypts of CASH-treated (A) and WASHtreated (B) mice. (C) Percent TUNEL-positive cells in cecal crypts (n ⫽ 3 mice [one-third of each tissue slide
was counted separately]; **, P ⫽ 0.0017). (D) Percent distance of distribution of TUNEL-positive cells from
the base to the top of the crypts (n ⫽ 3 mice [62 crypts with TUNEL-positive cells were counted per
group]; *, P ⬍ 0.0001 [unpaired t test with Welch’s corrections]).

TUNEL-positive cells was signiﬁcantly higher in the crypts of WASH-treated mice
(Fig. 5C), with signiﬁcantly larger amounts of TUNEL-positive cells in WASH-treated mice
localized at the crypt base, the stem cell compartment (Fig. 5D). Apoptosis at the crypt
base cells can lead to the loss of stem cells and impede the process of epithelial
regeneration and recovery, resulting in irreversible damage to the tissues.
WASH-treated mice harbor MDR strains of Serratia marcescens that express a
virulent and immunosuppressive phenotype. Culture demonstrates that S. marcescens is the dominant species in the cecum, blood, liver, and spleen, with a higher
prevalence in the WASH-treated mice versus CASH-treated mice (Fig. 6A). Among all S.
marcescens isolates from WASH-treated mice, 10 to 50% express an MDR phenotype
(Fig. 6B). MDR strains were deﬁned based on their resistance to ⱖ3 classes of antibiotics. Extended-spectrum ␤-lactamase (ESBL)-producing and carbapenem-resistant
strains of S. marcescens were ﬂagged in the group of MDR strains. Further analysis of 21
randomly selected strains from this group revealed that 76% (16 of 21) of the MDR
strains harbored an ESBL, and 95% (20 of 21) displayed resistance to meropenem
(Table 1). None of the isolates, produced carbapenemase based on negative mCIM
results. Importantly, no S. marcescens MDR strains were isolated in CASH-treated mice.
We tested the virulence of MDR isolates using Galleria mellonella. Results demonstrated
that among 19 MDR strains tested, 47% demonstrated a level of virulence similar to the
three tested sensitive strains, and 36% of MDR strains displayed an extremely high
virulence phenotype as judged by their ability to kill G. mellonella (Fig. 6C). The
virulence of a given strain was not speciﬁc to the organ from which it was isolated. For
example, of nine S. marcescens cecal isolates, two were found to be avirulent, and ﬁve
were extremely virulent, as judged by G. mellonella killing assays.

FIG 4 Legend (Continued)
of phyla (D) and genera (E) with relative abundances of ⬎2%. A P value of ⬍0.05 was determined with the Benjamini-Hochberg FDR correction in ANCOM.
(F) qPCR analysis of cecal tissue-associated S. marcescens: Western versus chow (*, P ⫽ 0.048, n ⫽ 5 per group) and WASH versus CASH (**, P ⫽ 0.0005, n ⫽ 5
per group), determined using an unpaired t test with Welch’s corrections. (G) Distribution of ESVs belonging to the genera Serratia and Pseudomonas. The
smaller inset shows the distribution of ESVs with low abundance (i.e., ⬍2%). (H) FISH analysis of cecal tissue of untreated chow-fed mice indicates the presence
of S. marcescens within a bacterial cluster inside a crypt (indicated by an arrow).
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FIG 6 Quantitative and qualitative analysis of retrieved strains of Serratia marcescens. (A) Frequency of
S. marcescens culture-positive organs in CASH and WASH treatment groups (n ⫽ 30 mice per group). (B)
Frequency of S. marcescens MDR strains among isolates. (C) Virulence/killing assays using Galleria
mellonella injected with selected antibiotic-sensitive and MDR strains of S. marcescens isolated from
WASH-treated mice. Time of incubation after injection, 14 h (n ⫽ 45 larvae per bacterial strain [15
larvae ⫻ 3 biological replicates]). L, liver; S, spleen. (D) Heat maps representing the expression of genes
encoding IL-1␤, IL-6, and IRF3 in MEF cells in response to ﬁltered lysates of S. marcescens and cecal
contents from chow-fed, Western diet-fed, and CASH- and WASH-treated groups. The data are normalized to the expression of GAPDH (n ⫽ 3 per group). Error bars indicate the SEM.

To test the effect of S. marcescens on the innate immune response, we performed
experiments using lysates of S. marcescens strains and cecal contents from chow-fed,
WD-fed, and CASH- and WASH-treated mice. Lysates were applied onto mouse embryonic ﬁbroblasts (MEFs) and immune responses tested in vitro (Fig. 6D) (17). Analysis by
quantitative reverse transcription-PCR (qRT-PCR) after 6 h of coincubation was performed for genes encoding IL-1␤ and IL-6 and the gene encoding interferon regulatory
factor 3 (IRF3), a key transcriptional regulator of type I interferons (IFNs) (18–20). The
results demonstrated that S. marcescens, both multidrug-resistant and sensitive strains,
upregulated the proinﬂammatory genes encoding IL-1␤ and IL-6 and downregulated
the gene encoding IRF3. Higher concentrations of lysates were required for CASH to
induce the same level of expression of proinﬂammatory genes, but IRF3 did not
respond even at a high dose (1 g of protein/ml) (Fig. 6D). Cecal lysates from chow-fed
July/August 2019 Volume 10 Issue 4 e00903-19

mbio.asm.org 9

®

Hyoju et al.

TABLE 1 ESBL and mCIM test in group of MDR S. marcescens strainsa
Strainb
T56447

2

T23150

3

T23157

4

T23147

5

T56439

6

T56441

7

T56443

8

T56444

9

F75150 (13)

10

F75151 (16)

11

F75152 (17)

12

F75147 (8)

13

F75148 (9)

14

F75149 (10)

15

F75150 (12)

16

T23208

17

T23213

18

F75144 (4)

19

T56430

20

T56432

21

T56434

aPOS,

Source
WASH
cecum
WASH
blood
WASH
blood
WASH
blood
WASH
blood
WASH
blood
WASH
liver
WASH
spleen
WASH
cecum
WASH
cecum
WASH
cecum
WASH
cecum
WASH
cecum
WASH
cecum
WASH
cecum
WASH
blood
WASH
blood
WASH
cecum
WASH
blood
WASH
blood
WASH
liver

Antibiotic resistance
Cefepimer, ceftazidimer, ceftriaxoner, ciproﬂoxacini, ertapenemr,
gentamicinr, levoﬂoxacini, meropenemr, piperacillinr
Cefepimer, ceftazidimer, ceftriaxoner, ciproﬂoxacinr, ertapenemr,
gentamicinr, levoﬂoxacinr, meropenemr, piperacillinr
Cefepimer, ceftazidimer, ceftriaxoner, ciproﬂoxacinr, ertapenemr,
gentamicinr, levoﬂoxacinr, meropenemr, piperacillinr
Cefepimer, ceftazidimer, ceftriaxoner, ciproﬂoxacini, ertapenemr,
gentamicini, levoﬂoxacini, meropenemr, piperacillinr
Cefepimer, ceftazidimer, ceftriaxoner, ciproﬂoxacini, ertapenemr,
gentamicinr, levoﬂoxacini, meropenemr, piperacillinr
Cefepimer, ceftazidimer, ceftriaxoner, ciproﬂoxacini, ertapenemr,
gentamicinr, levoﬂoxacini, meropenemr, piperacillinr
Cefepimer, ceftazidimer, ceftriaxoner, ciproﬂoxacini, ertapenemr,
gentamicinr, levoﬂoxacini, meropenemr, piperacillinr
Cefepimer, ceftazidimer, ceftriaxoner, ciproﬂoxacini, ertapenemr,
gentamicinr, levoﬂoxacini, meropenemr, piperacillinr
Cefepimer, ceftazidimer, ceftriaxoner, ciproﬂoxacini, ertapenemr,
gentamicinr, levoﬂoxacini, meropenemr, piperacillinr
Cefepimer, ceftazidimer, ceftriaxoner, ciproﬂoxacini, ertapenemr,
gentamicinr, levoﬂoxacini, meropenemr, piperacillinr
Cefepimer, ceftazidimer, ceftriaxoner, ciproﬂoxacini, ertapenemr,
gentamicinr, levoﬂoxacini, meropenemr, piperacillinr
Cefepimer, ceftazidimer, ceftriaxoner, ciproﬂoxacini, ertapenemr,
gentamicinr, levoﬂoxacini, meropenemr, piperacillinr
Cefepimer, ceftazidimer, ceftriaxoner, ciproﬂoxacini, ertapenemr,
gentamicinr, levoﬂoxacini, meropenemr, piperacillinr
Cefepimer, ceftazidimer, ceftriaxoner, ciproﬂoxacini, ertapenemr,
gentamicinr, levoﬂoxacini, meropenemr, piperacillinr
Cefepimer, ceftazidimer, ceftriaxoner, ciproﬂoxacini, ertapenemr,
gentamicinr, levoﬂoxacini, meropenemr, piperacillinr
Cefepimer, ceftazidimer, ceftriaxoner, ciproﬂoxacini, ertapenemr,
gentamicinr, levoﬂoxacini, meropenemr, piperacillinr
Cefepimer, ceftazidimer, ceftriaxoner, ciproﬂoxacini, ertapenemr,
gentamicini, levoﬂoxacini, meropenemr, piperacillinr
Gentamicinr, piperacillinr, tobramycinr, trimethoprim/
sulfamethoxoler
Cefepimer, ceftazidimer, ceftriaxoner, ciproﬂoxacini, ertapenemr,
gentamicinr, levoﬂoxacini, meropenemr, piperacillinr
Cefepimer, ceftazidimer, ceftriaxoner, ciproﬂoxacini, ertapenemr,
gentamicinr, levoﬂoxacini, meropenemr, piperacillinr
Cefepimer, ceftazidimer, ceftriaxoner, ciproﬂoxacini, ertapenemr,
gentamicinr, levoﬂoxacini, meropenemr, piperacillinr

ESBL
POS

mCIM
NEG

POS

NEG

NEG

NEG

POS

NEG

POS

NEG

POS

NEG

POS

NEG

POS

NEG

POS

NEG

NEG

NEG

POS

NEG

NEG

NEG

POS

NEG

POS

NEG

POS

NEG

POS

NEG

NEG

NEG

NEG

NEG

POS

NEG

POS

NEG

POS

NEG

positive; NEG, negative; r, resistance; i, intermediate resistance.
in parentheses indicate no. of isolates.

bNumbers

mice and mice fed a Western-type diet did not stimulate MEF cells (Fig. 6D). Given the
downregulated response of IRF3 and its critical role in the immune response via type
I IFNs, we performed a ﬂow cytometry analysis of blood collected from CASH- and
WASH-treated mice and compared it to chow-fed mice as a control. The results
demonstrated a signiﬁcant attenuation of B cells in both CASH- and WASH-treated
mice, with a trend toward attenuation in WASH-treated mice and a signiﬁcant decrease
in naive and central memory CD4 T cells in WASH-treated mice (see Fig. S3 in the
supplemental material). We also performed reiterative experiments comparing S. marcescens and E. faecalis, bacteria that were cultured from cecal tissue-associated microbiota. E. faecalis did not stimulate MEF cells to express proinﬂammatory genes (see
Fig. S4 in the supplemental material). An additional bacterium isolated in this model,
Enterobacter cloacae, stimulated MEF cells in a pattern similar to that for S. marcescens
(see Fig. S4 in the supplemental material). This pathogen was isolated in several
reiterative experiments in WASH-treated mice in which mortality was not associated
with S. marcescens, but rather E. cloacae disseminated in the blood, liver, and spleen. In
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this experiment, similar to S. marcescens, E. cloacae expressed the MDR phenotype but
did not produce ESBL or carbapenemase enzymes.
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DISCUSSION
By combining the effects of an obesogenic diet and antibiotic exposure, we observed spontaneous emergence and dissemination of pathobionts associated with
organ damage and lethality following an otherwise recoverable surgical injury. Surprisingly, among the isolated pathogens, ⬃20% displayed an MDR phenotype that appeared unrelated to the antibiotics used in this model. The results from the present
study support the observations in humans that MDR pathogens causing bacteremia in
patients may emerge from the intestinal microbiome rather than from a grossly
infected organ or direct environmental contamination (6, 7, 21).
Surgery was required for mortality to occur in this model. Not only is the physiologic
stress of surgical injury known to cause collapse of microbiota community structure and
function (22, 23), but it is also known to alter intestinal barrier function and accelerate
intestinal apoptosis, two interrelated events (24). However, intestinal barrier function
alterations following surgical injury alone (such as burn, trauma, or hemorrhagic shock)
rarely if ever lead to lethality perhaps owing to the fact that the organisms that
translocate under these circumstances are mainly commensal Escherichia coli, which
translocate at low bacterial density and which themselves are not lethal pathogens
(23, 25).
Interestingly, the species of pathobionts that emerged in the current model, S.
marcescens and E. cloacae, are often those found in ultralow-diversity communities in
critically ill patients with organ failure and sepsis (26). The difﬁculty in detecting these
pathogens preoperatively may be due to their being camouﬂaged within hidden niches
of the gut, such as the cecal crypts (16). Bacteroides persisted in the cecal mucosa of
CASH-treated mice and may have played a role in preventing mortality via its ability to
produce short-chain fatty acids, suppress pathobionts even in the face of antibiotics
and surgery, and its ability to preserve the mucosal mucus layer and barrier function
(27).
In cases of both human and experimental sepsis, bacteremia is both rare and highly
variable (28–30). Less than one-third of patients with severe sepsis are found to have
bacteria in their blood either by culture or PCR (28–30). We were able to detect, among
WASH-treated mice, signiﬁcant bacteremia and culture positivity in the liver, spleen,
and blood compared to culture negativity across all sites among the other treatment
groups (CASH, CSH, and WSH). Although causality between bacterial dissemination and
mortality was not established in this model, the ability to capture and characterize MDR
S. marcescens and others in WASH-treated mice suggests that multiple perturbations to
the intestinal microbiota, including diet, antibiotic exposure, and surgery, are needed
for this to occur, although it does not occur in all WASH-treated mice. The exact
mechanism by which S. marcescens developed resistance to carbapenem remains to be
determined, but, given the lack of carbapenemase production, we hypothesized that
this observed carbapenem resistance was likely due to the hyperproduction of AmpC
␤-lactamase (31). There are several potential explanations for how MDR strains might
have emerged in this model. First, they may have been introduced into the mouse gut
from the local environment (housing facility, during transportation, etc.). Second, they
may have been part of the normal ﬂora and were selected for by the conditions of
WASH treatment. Finally, it is possible that commensal strains were transformed to MDR
strains by effects of WASH treatment on their evolutionary trajectory. The latter
possibility is supported by existing evidence demonstrating that microbes can become
antibiotic resistant without being exposed to the speciﬁc antibiotics that confer resistance (32). Testing this possibility will require serial genetic tracking of the intestinal
microbiota at the strain level, as well as ultradeep sequencing. In addition, there is
evidence that antibiotic-resistant strains are normal members of the intestinal microbiome (33). Also relevant to the present study is the observation that obese patients are
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more likely to harbor bacterial resistance genes (34) and are also more susceptible to
postoperative infections (35).
Potential mechanisms of any of the above possibilities may relate, in part, to the
known increase in bile acid synthesis observed in obese hosts (36). The potent
antimicrobial activity of bile acids has been shown to directly regulate the gut microbiota (37, 38), including effects such as the disruption of bacterial membranes, the
denaturation of proteins, the chelation of iron and calcium, the oxidative damage of
DNA, etc. (39). Furthermore, a Western-type diet has been demonstrated to increase
oxidative stress (40, 41), which can also impact the emergence of antibiotic resistance
(42–44). Finally, it is possible that WASH treatment eliminates epithelial protective
Bacteroidetes and other microbiota that competitively suppress the pathobionts. Without Bacteroides and other cytoprotective microbiota, enteric pathogens can disseminate, as observed here in the WASH-treated mice (Fig. 2D).
A limitation of this study is that the precise compositional elements responsible for
the effect of diet on the composition of gut microbiota in this model are unknown since
the two diets varied signiﬁcantly in fatty acids, ﬁber content, carbohydrates, minerals,
and vitamins. Any number of combinations of these nutrients could potentially inﬂuence the observed decrease in Bacteroidetes (45, 46) and Actinobacteria (47, 48) and the
bloom of Proteobacteria (49, 50). Now that the model is fully characterized up to the
endpoint of organ damage and lethality, reiterative studies using various single nutrients and related groups of nutrients can be carried out. Similarly, changing the type
and duration of antibiotic exposure, the environmental factors (sleep, social stress, etc.),
the background microbiota, and the mouse genetics is now possible in this model.
Another limitation is that mice were not housed separately for 6 weeks after randomization to the speciﬁc diets, which may have introduced a “cage effect” on the
microbiota. However, given the multiple experimental runs, the reproducibility of the
impact of diet on the microbiota, and the large sample size, the direct inﬂuence of
the cage effect on our results is likely to have been minimized.
In summary, we present here a novel model of lethal sepsis occurring without the
introduction of an exogenous pathogen and without creating a gross untreated
infection such as occurs with the cecal ligation and puncture model. The model
described here may advance our understanding of the mortality of human sepsis,
which most often involves MDR pathogens, immunosuppression, and the absence of an
active untreated infectious focus.
MATERIALS AND METHODS
Animals. Male C56BL/6 mice (Charles River laboratory), 6 weeks old, with an average weight of 22 g
(range, 20 to 24 g) were used. The mice were housed in a temperature-controlled 12-h light/dark cycled
room at the University of Chicago animal facility for 1 week. Mice were randomly assigned to ad libitum
feeding of either standard mouse chow (Envigo) or a Western-type diet (Bio Serve, mouse high-fat diet,
catalog no. S3282) (see Table S1 in the supplemental material). To avoid social isolation stress, mice were
housed at ﬁve mice per cage for 6 weeks after random assignment to their respective diets. Mice were
weighed every 3 days. All experiments were performed in accordance with the National Institutes of
Health (NIH) guidelines, and approval was obtained from the University of Chicago Animal Care and Use
Committee (protocol 71744).
Surgical procedure. Following dietary allocation, antibiotics were administered as a combination of
cefoxitin and clindamycin. Cefoxitin (30 mg/kg; Hikma Pharmaceutical, Eatontown, NJ) was administered
subcutaneously, and clindamycin (70 mg/kg; Clindrops; Henry Schein, Dublin, OH) was administered by
gavage twice daily for 5 days before surgery. Five days of antibiotic exposure was necessary for
sepsis/mortality to develop in this model (data not shown). Mice were individually housed and only given
water for 14 h prior to surgery. Mice were anesthetized by intraperitoneal injection of ketamine at
80 mg/kg and xylazine at 10 mg/kg, with injection of buprenorphine at 0.05 at mg/kg 30 min before
anesthesia. The abdomen was sterilely prepared and left lobe of liver excised bloodlessly. For recovery,
mice received a subcutaneous injection of 1 ml of warm saline (37°C) and buprenorphine at 8 h. Mice
were assessed every 6 h according to standard sepsis scoring system: score 1, ambulatory, active, normal
fur coat, normal amount of feces (normal); score 2, ambulatory, active, rufﬂed fur (mild sepsis); score 3,
rufﬂed fur, hunched posture, increased respirations (moderate sepsis); score 4, rufﬂed fur, hunched
posture, increased respirations, slowly staggering gait in response to touch (severe sepsis); and score 5,
animal on side, minimally responsive, rapid shallow respirations, gasping (moribund).
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Sample collection. Blood was collected aseptically by direct cardiac puncture. A portion of the liver
and spleen was homogenized for culture. Cecal tissue and content were collected in 10% glycerol for
culture and frozen for DNA extraction. Finally, lung and cecal tissue were ﬁxed in formalin for histology.
Bacterial culture. Portions (100 l) of blood, liver, and spleen homogenates were serially diluted and
plated on MacConkey and Columbia nalidixic acid agar plates (BD Difco), and the CFU counted at 24 h.
IL-6 and CRP serum assays. CRP and IL-6 concentrations were assayed using commercially available
kits (BD OptEIA; R&D Systems, Minneapolis, MN).
16S rRNA sequencing and sequence data analysis. Microbial DNA extraction from cecal contents
was performed using a PowerSoil DNA isolation kit (MoBio, Carlsbad, CA). Tissues were homogenized,
and DNA was extracted using an UltraClean tissue and cells DNA isolation kit (MoBio). For library
preparation, DNA was ampliﬁed using the barcoded 12-bp Golay primer set designed for the Earth
Microbiome Project (EMP) (51). PNAClamp technology (PNA Bio) was used to prevent the ampliﬁcation
of the murine 16S mitochondrial region. For each sample, PCR was performed according to the
manufacturer’s protocol using the EMP primers, mPNA, AccuStart II PCR ToughMix, and the extracted
DNA (Quntabio). Since the PNA requires a hold at 75°C for 10 s in order to “clamp” onto contaminant
DNA, the standard EMP 16S PCR schedule was modiﬁed to the following: 94 for 3 min; 35 cycles of 94
for 45 s, 75 for 10 s, 50 for 1 min, and 72 for 1.5 min; and a ﬁnal extension at 72 for 10 min. After
ampliﬁcation, the PCR products were quantiﬁed by using a PicoGreen dsDNA quantitation assay
(Invitrogen). The results of the quantiﬁcation were then used to normalize the amount of DNA from the
PCR product to use for sequencing and to ensure that each amplicon was represented evenly during
sequencing. These volumes were then sequentially consolidated into a single tube using an OpenTrons
liquid-handler running a custom Python script. Finally, an aliquot of the ﬁnal pool was taken, and the
DNA was puriﬁed by using an Agencourt AMPure XP PCR* puriﬁcation system (Beckman-Coulter). The
samples were then run on an Illumina MiSeq at the University of Illinois at Chicago (150 bp ⫻ 2). The data
are available in EMBL-ENA under BioProject ID PRJEB32897 (secondary accession no. ERP115632), along
with the metadata.
For 16S rRNA gene sequence analysis, the paired-end reads were joined using the join_paired_ends.py script, followed by quality ﬁltering and demultiplexing using the split_libraries_fastq.py script in
QIIME (52). The ﬁnal set of demultiplexed sequences was then selected for ESV picking using the DeBlur
pipeline (53). To improve downstream network analysis, ESVs present in ⱕ10 samples were also
removed. The data were also rareﬁed to a depth of 10,000 reads per sample. Alpha and beta diversities
were analyzed using the Phyloseq and MicrobiomeSeq package in R. For the alpha diversity, the Shannon
index was used, and the beta diversity was analyzed using nonmetric multidimensional scaling (NMDS)
plots that were generated based on a weighted UniFrac dissimilarity matrix. Assessment of statistical
signiﬁcance of alpha and beta diversity trends was performed using permutational analysis of variance
(PERMANOVA). To determine signiﬁcantly different ESVs between groups of interest, an analysis of
composition of microbiome (ANCOM) pipeline was used at P value (false discovery rate [FDR]) cutoff of
⬍0.05.
TUNEL analysis. TUNEL staining was performed using an ApopTag Plus Peroxidase In Situ apoptosis
detection kit (Millipore) as previously described (54). Determination of the TUNEL-positive cell fraction
was performed by color deconvolution of scanned gut images, followed by setting the threshold to a
positive signal and determination of the area fraction by using built-in Fiji plugins. The distribution of
TUNEL cells per villus was automated using a custom macro script in Fiji. Villi were traced with a wide
line region of interest, the villus was straightened and rotated to be horizontal with the base on the left,
the positive cells were identiﬁed using a manually conﬁrmed threshold, and the distance to each cell
centroid was determined relative to the villus tip using standard Fiji plugins. Aligned villi were assembled
into a common (minimum) projection to pictorially show the location of cells along the villi.
FISH staining. FISH staining for visualization of S. marcescens was performed as previously described
(54) using a probe S. marcescens Alexa Fluor488 designed by MetaSystems Indigo GmbH, Altusscheim,
Germany, which uses a next generation FISH beacon-based technology. A bacterial universal Texas red
probe was applied for dual staining. Confocal microscopy was performed on a Leica SP5 II AOBS tandem
scanner spectral confocal system on a DMI6000 microscope and controlled by LASAF software (v2.8.3).
MEF experiments. C57BL/6 primary MEFs were obtained from 12.5 to 14.5 days postcoitus embryos
and cultured in Dulbecco modiﬁed Eagle medium (Gibco) supplemented with 10% fetal bovine serum
(Gibco) and 1% nonessential amino acids (Gibco). MEFs were plated at a density of 2.5 ⫻ 105/ml in
24-well plates (Costar) overnight. Pathogen lysates were prepared by taking live pathogens in culture,
resuspension in PBS, bead beating with 0.1-mm-diameter glass beads (BioSpec) for 5 min, and ﬁltration
using a Millex-GV 0.22-m-pore-size ﬁlter (Millipore). Cecal content lysates were prepared by bead
beating cecal contents with 0.1-mm-diameter glass beads (BioSpec) for 5 min and ﬁltration using a
Millex-GV 0.22-m-pore-size ﬁlter (Millipore). Protein concentrations were measured by using a BCA
protein assay kit (Thermo Fisher Scientiﬁc). Plates were incubated at 37°C and 5% CO2 for 6 or 12 h with
the addition of lysates; the culture medium was then removed, and the cells were harvested in RLT Plus
buffer (Qiagen) with 1% 2-mercaptoethanol (Sigma). RNA extraction was performed using an RNeasy Plus
minikit (Qiagen) according to the manufacturer’s instructions. Two independent experiments were
performed, with technical replicates.
Transcriptional analysis of MEFs using qRT-PCR assay. RNA was converted to cDNA using reverse
transcriptase (Promega) according to the manufacturer’s instructions. Samples were run in duplicate via
qPCR on a Roche LightCycler 480 using SYBR Advantage qPCR Premix (Clontech). The expression levels
were quantiﬁed and normalized to housekeeping gene GAPDH (glyceraldehyde-3-phosphate dehydrogenase). The following qPCR primer pairs were custom ordered from Integrated DNA Technologies:
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IL1␤-F (GAAATGCCACCTTTTGACAGTG) and IL1␤-R (TGGATGCTCTCATCAGGACAG); IL-6-F (CCAAGAGGTG
AGTGCTTCCC) and IL-6-R (CTGTTGTTCAGACTCTCTCCCT); IRF3-F (GAGAGCCGAACGAGGTTCAG) and
IRF3-R (CTTCCAGGTTGACACGTCCG); and GAPDH-F (AGGTCGGTGTGAACGGATTTG) and GAPDH-R (TGTA
GACCATGTAGTTGAGGTCA).
Microbial phenotype microarray. The GEN III MicroPlate test panel (Biolog, Hayward, CA) was used
to determine the phenotypic ﬁngerprint of microbial community in chow-fed, WD-fed, CASH-, and
WASH-treated mice. Cecal contents were collected in saline with 10% glycerol and in saline with 10%
glycerol and 1% cysteine (to preserve anaerobic bacteria) at the time of sacriﬁce and stored at – 80°C until
use. Samples were centrifuged at 100 rpm for 1 min to remove tissue debris, and the bacterial cell
suspension was diluted in saline to an optical density at 600 nm of 0.25. Then, 50 l of the sample was
introduced in the IF-A inoculation ﬂuid vial (Biolog). Each diluted sample was placed on 96-well GENIII
microplates (Biolog), followed by incubation for 22 h at 37°C in an OmniLog incubator/reader (Biolog).
Processing of anaerobic samples was performed in anaerobic chamber, and the plates were sealed with
Microseal B seal (Bio-Rad). Data analysis was performed with the statistical program R and the “opm”
package. Growth curve parameters (area under the concentration-time curve [AUC] and maximum) were
aggregated from the data using the “do_aggr” function. The data were normalized to the AUC of the
negative control, since this was the well on the plate without substrate to affect the growth of the
microbial community in the samples. Heat maps and radial plots were created using the “heat_map” and
“radial_plot” functions. Pairwise comparisons (analysis of variance) between the groups was performed
with the “opm_mcp” function.
Bacterial identiﬁcation and antibiotic resistance proﬁling. Bacterial identiﬁcation was performed
on the Vitek MS (bioMérieux, Inc., Durham, NC). Susceptibility testing of Gram-negative bacilli was
performed using the Vitek 2 XL system (bioMérieux) using the AST-GN75 card. Conﬁrmatory testing for
ESBL production was performed on Mueller-Hinton agar using cefotaxime and ceftazidime disks, with or
without clavulanic acid (BD, Franklin Lakes, NJ). A difference of ⱖ5 mm in zone size between the
clavulanic acid-containing disks and the disks without clavulanic acid was considered positive for ESBL
production. The modiﬁed carbapenem inactivation method (mCIM) was performed to detect carbapenemase production. The test was performed as described in the 28th edition of the Clinical and Laboratory
Standards Institute supplement M100 (55).
Statistical analysis. Data were analyzed using Prism (GraphPad Software, San Diego, CA). The results
were expressed as means ⫾ the standard errors of the means (SEM). Nonparametric Mann-Whitney,
one-way ANOVA test, and the log rank test (Mantel-Cox test) were used to test the statistical signiﬁcance.
A P value of ⬍0.05 was considered signiﬁcant. The statistical program R and the “opm” package provided
by Biolog were used to analyze phenotypic microarray data.
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